Achat d’initiés au cours des 6 derniers mois | Titres | Trans. |
---|---|---|
Achats | 0 | 0 |
Ventes | S.O. | 0 |
Titres nets achetés (vendus) | 0 | 0 |
Total des titres d’initiés détenus | 2,72M | S.O. |
% des titres nets acquis (vendus) | S.O. | S.O. |
Achats institutionnels nets à partir du trimestre précédent jusqu’au dernier trimestre | Titres |
---|---|
Titres nets achetés (vendus) | S.O. |
% de variation dans les titres institutionnels détenus | S.O. |
Initié | Transaction | Type | Valeur | Date | Titres |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 2.21 per share. | Indirect | 4 095 130 | 06 janv. 2023 | 1 853 000 |
SEIDEL-DUGAN CYNTHIA PH.D. | Conversion of Exercise of derivative security at price 1.56 - 4.77 per share. | Direct | 111 838 | 12 janv. 2022 | 39 731 |
LEONARD REID | Conversion of Exercise of derivative security at price 1.56 per share. | Direct | 21 999 | 30 déc. 2021 | 14 102 |
LEONARD REID | Sale at price 13.39 - 13.97 per share. | Indirect | 40 242 | 15 déc. 2021 | 3 000 |
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 12.75 - 13.37 per share. | Indirect | 4 129 398 | 16 juin 2021 | 323 298 |
EVNIN LUKE BASIL | Purchase at price 16.00 per share. | Indirect | 2 412 784 | 04 mai 2021 | 150 799 |
EVNIN LUKE BASIL | Indirect | 04 mai 2021 | 3 671 965 | ||
HBM HEALTHCARE INVESTMENTS CAYMAN LTD | Direct | 04 mai 2021 | 625 995 | ||
GADICKE ANSBERT S. | Purchase at price 16.00 per share. | Indirect | 3 920 000 | 04 mai 2021 | 245 000 |
GADICKE ANSBERT S. | Indirect | 04 mai 2021 | 5 965 775 | ||
UPMC | Direct | 04 mai 2021 | 1 097 756 | ||
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 16.00 per share. | Indirect | 27 440 000 | 04 mai 2021 | 1 715 000 |
RA CAPITAL MANAGEMENT, L.P. | Indirect | 04 mai 2021 | 2 253 583 | ||
FLYNN JAMES E | Purchase at price 16.00 per share. | Indirect | 12 800 000 | 04 mai 2021 | 800 000 |
FLYNN JAMES E | Indirect | 04 mai 2021 | 1 752 787 | ||
MPM BIOVENTURES 2014,L.P. | Purchase at price 16.00 per share. | Indirect | 2 012 144 | 04 mai 2021 | 125 759 |
MPM BIOVENTURES 2014,L.P. | Indirect | 04 mai 2021 | 3 062 239 | ||
LAZARUS ALON | Purchase at price 16.00 per share. | Indirect | 6 400 000 | 04 mai 2021 | 400 000 |
LAZARUS ALON | Indirect | 04 mai 2021 | 1 646 634 | ||
ASANUMA SAKAE | Purchase at price 16.00 per share. | Indirect | 5 000 000 | 04 mai 2021 | 312 500 |
ASANUMA SAKAE | Indirect | 04 mai 2021 | 1 756 409 | ||
ARKIN BIO VENTURES 2, LP. | Purchase at price 16.00 per share. | Indirect | 6 400 000 | 04 mai 2021 | 400 000 |
ARKIN BIO VENTURES 2, LP. | Indirect | 04 mai 2021 | 1 646 634 | ||
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Purchase at price 16.00 per share. | Indirect | 7 600 000 | 04 mai 2021 | 475 000 |
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Indirect | 04 mai 2021 | 312 997 | ||
TAIHO VENTURES, LLC | Purchase at price 16.00 per share. | Direct | 5 000 000 | 04 mai 2021 | 312 500 |
TAIHO VENTURES, LLC | Direct | 04 mai 2021 | 1 756 409 | ||
LONGWOOD FUND III GP, LLC | Purchase at price 16.00 per share. | Indirect | 4 000 000 | 04 mai 2021 | 250 000 |
LONGWOOD FUND III GP, LLC | Indirect | 04 mai 2021 | 1 427 082 |